|
|
 |
|
Viewing report
|
|
|
|
Aggregation of Therapeutic Proteins
John Wiley and Sons Ltd, Sep 2010, Pages: 484
This book gives pharmaceutical scientists an up-to-date resource on protein aggregation and its consequences, and available methods to control or slow down the aggregation process. While significant progress has been made in the past decade, the current understanding of protein aggregation and its consequences is still immature. Prevention or even moderate inhibition of protein aggregation has been mostly experimental.
The knowledge in this book can greatly help pharmaceutical scientists in the development of therapeutic proteins, and also instigate further scientific investigations in this area. This book fills such a need by providing an overview on the causes, consequences, characterization, and control of the aggregation of therapeutic proteins.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Development of Vaccines: From Discovery to Clinical Testing
GPCR Molecular Pharmacology and Drug Targeting: Shifting Paradigms and New Directions
Characterization of Impurities and Degradants Using Mass Spectrometry
Drug Delivery in Cancer - Technologies, Markets and Companies
Lipid Nanocarriers in Cancer Diagnosis and Therapy
Carbohydrate-Based Vaccines and Immunotherapies
Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects
Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals
Cancer Drug Resistance
A Guide to Biosimilars, Biogenerics and Follow-On Biologics
|
|
|
|
